43 results on '"Di Fiore, Fréderic"'
Search Results
2. Trifluridine/tipiracil + oxaliplatin ± nivolumab vs FOLFOX ± nivolumab in HER2 negative advanced oesogastric adenocarcinoma: The PRODIGE73-UCGI40-LOGICAN trial
3. A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability
4. Prognostic value of circulating short-length DNA fragments in unresected glioblastoma patients
5. Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study
6. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
7. Evaluation of sarcopenia biomarkers in older patients undergoing major surgery for digestive cancer. SAXO prospective cohort study
8. Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial
9. Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27)
10. COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)
11. Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI)-PRODIGE 62: A multicentre, randomised, non-comparative phase II study
12. Patients’ perception and attitude to totally implantable venous access for urologic or digestive cancer: A cross-sectional study
13. CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts
14. Clinical Relevance of Gene Copy Number Variation in Metastatic Clear Cell Renal Cell Carcinoma
15. Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK)
16. Benefit of cetuximab addition to a platinum–fluorouracil-based chemotherapy according to KRAS-LCS6 variant in an unselected population of recurrent and/or metastatic head and neck cancers
17. Influence of adjuvant chemotherapy on anti-Müllerian hormone in women below 35 years treated for early breast cancer
18. Place des biopsies liquides dans le diagnostic et la caractérisation moléculaire des cancers du sein: Role of liquid biopsies in the diagnosis and molecular characterization of breast cancer
19. Evaluating lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours
20. Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma
21. Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer
22. Bevacizumab plus FOLFIRI after failure of platinum–etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial
23. Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer
24. Chapitre 75 - Cancer colorectal
25. Impact of nutritional parameter variations during definitive chemoradiotherapy in locally advanced oesophageal cancer
26. Associations between the severity of medical and surgical complications and perception of surgeon empathy in esophageal and gastric cancer patients
27. 18F-fluorodeoxyglucose positron emission tomography after definitive chemoradiotherapy in patients with oesophageal carcinoma
28. Metastatic colorectal cancer KRAS genotyping in routine practice: results and pitfalls
29. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
30. Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations
31. Acute and long-term gastrointestinal consequences of chemotherapy
32. Impact of radiation schedule and chemotherapy duration in definitive chemoradiotherapy regimen for esophageal cancer
33. Chimiothérapie adjuvante du cancer gastrique
34. Palliative esophageal stent placement using endoscopic guidance without fluoroscopy
35. Colorectal cancer with non-resectable synchronous metastases: should the primary tumor be resected?
36. Scrotal Metastasis From a Nonmuscle-infiltrative Bladder Cancer: A Surprising Clinical Evolution
37. Benefit of cetuximab addition to a platinum–fluorouracil-based chemotherapy according to KRAS-LCS6 variant in an unselected population of recurrent and/or metastatic head and neck cancers
38. Direct circulating tumor DNA detection from unpurified plasma using a digital PCR platform
39. TERTp Mutation Detection in Plasma by Droplet-Digital Polymerase Chain Reaction in Spinal Myxopapillary Ependymoma with Lung Metastases
40. Photodynamic Therapy in Superficial Esophageal Cancer: A Comparison Between Patients Treated in Primary Intent and Patients Treated As a Salvage Therapy After Local Failure of Chemoradiotherapy
41. Double Stenting of Esophagus and Airways in Patients with Locally Advanced Esophageal Cancer: Feasibility, Efficacy and Complications
42. Self-Expanding Metal Stents (SEMS) in Palliation of Esophageal Cancer: Post-Procedure Life-Threatening Complications in 56 Patients with Prior Chemoradiotherapy vs 60 Patients without Prior Treatment
43. Analysis of the allele-specific expression of the mismatch repair gene MLH1 using a simple DHPLC-Based Method.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.